Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
reallypeople?'s Profile
Displaying 1351-1400 of 1754 result(s).
CYDY CytoDyn Inc
05/14/2020 6:46:51 PM
Look at this . New trial we can eas
CYDY CytoDyn Inc
05/14/2020 3:48:12 PM
Just to clarify ...This last deal ?
CYDY CytoDyn Inc
05/14/2020 2:46:09 PM
Oh sure .. Whats the name of the pe
CYDY CytoDyn Inc
05/14/2020 2:40:00 PM
Half of them have good links or inf
CYDY CytoDyn Inc
05/14/2020 2:13:19 PM
I bet if the company had to do it a (1)
CYDY CytoDyn Inc
05/14/2020 2:06:16 PM
I believe the last deal DID NOT HAV
CYDY CytoDyn Inc
05/14/2020 12:34:29 PM
More In all 12 cases, the cause of
CYDY CytoDyn Inc
05/14/2020 12:32:33 PM
Triple tasking .. DR MIKE .. He sup
CYDY CytoDyn Inc
05/14/2020 12:27:04 PM
Re-read it i think you will underst
CYDY CytoDyn Inc
05/14/2020 12:18:17 PM
Do a go fund me type deal for futur (1)
CYDY CytoDyn Inc
05/14/2020 12:13:31 PM
Exclude them .Limit it to people th
CYDY CytoDyn Inc
05/14/2020 11:18:11 AM
As @SecAzar explains, @POTUS has an
CYDY CytoDyn Inc
05/14/2020 11:13:15 AM
I wonder if the entity that came in
CYDY CytoDyn Inc
05/14/2020 11:05:30 AM
I agree with that (very reasonable
CYDY CytoDyn Inc
05/14/2020 10:25:54 AM
CDiddy I get that’s. Been around
CYDY CytoDyn Inc
05/14/2020 9:50:33 AM
On phone but will go desktop . Some
CYDY CytoDyn Inc
05/14/2020 9:47:16 AM
Any deal collaboration or licensing
CYDY CytoDyn Inc
05/14/2020 9:27:32 AM
12-18 months of cash .... Someone m (1)
CYDY CytoDyn Inc
05/13/2020 11:42:47 PM
Double-blind, Placebo-controlled St
CYDY CytoDyn Inc
05/13/2020 10:07:28 PM
Thanks longest (1)
CYDY CytoDyn Inc
05/13/2020 10:05:42 PM
Running the trial . I don’t think
CYDY CytoDyn Inc
05/13/2020 7:26:27 PM
Anyone remember a post here that me
CYDY CytoDyn Inc
05/13/2020 6:31:14 PM
Smurf or smlf has me on ignore . Bu
CYDY CytoDyn Inc
05/13/2020 6:08:29 PM
Gotta say . I agree with your state
CYDY CytoDyn Inc
05/13/2020 5:57:29 PM
Has to be way easier than the deal (1)
CYDY CytoDyn Inc
05/13/2020 5:53:24 PM
Thanks for the link to the replay . (3)
CYDY CytoDyn Inc
05/13/2020 4:23:18 PM
I want a upfront license deal . Don
CYDY CytoDyn Inc
05/13/2020 3:50:20 PM
I totally agree . As I said yesterd (1)
CYDY CytoDyn Inc
05/13/2020 3:44:08 PM
Just block me . I have also posted (1)
CYDY CytoDyn Inc
05/13/2020 10:05:07 AM
We will see what pops up to debate (1)
CYDY CytoDyn Inc
05/13/2020 10:03:49 AM
When you hear the fda say accepted (1)
CYDY CytoDyn Inc
05/13/2020 10:01:31 AM
LOL . I know we have been over this (5)
CYDY CytoDyn Inc
05/13/2020 8:35:54 AM
Doing some searching ran across thi (1)
CYDY CytoDyn Inc
05/13/2020 8:27:17 AM
Fauci more than likely talking abou
CYDY CytoDyn Inc
05/13/2020 8:24:33 AM
I posted this one yesterday Ibalizu
CYDY CytoDyn Inc
05/13/2020 8:18:57 AM
Correct spelling Tocilizumab (1)
CYDY CytoDyn Inc
05/13/2020 8:17:38 AM
Don’t know if it’s hiv related
CYDY CytoDyn Inc
05/13/2020 8:01:04 AM
Thank you Cytodyn
CYDY CytoDyn Inc
05/12/2020 10:43:31 PM
The big question for tomorrow. Did (1)
CYDY CytoDyn Inc
05/12/2020 9:53:06 PM
That’s fine . I have no problem w
CYDY CytoDyn Inc
05/12/2020 9:40:58 PM
I sent a couple private messages in
CYDY CytoDyn Inc
05/12/2020 9:37:53 PM
Typing fast it’s NO .. NOT KNOW
CYDY CytoDyn Inc
05/12/2020 9:37:09 PM
He’ll know I can read . But I’m (1)
CYDY CytoDyn Inc
05/12/2020 9:11:41 PM
We have all the data and blood work
CYDY CytoDyn Inc
05/12/2020 9:02:16 PM
We will see . They gonna PR the dat
CYDY CytoDyn Inc
05/12/2020 8:10:29 PM
Way behind us https://www.sciencema
CYDY CytoDyn Inc
05/12/2020 8:09:26 PM
ibalizumab. ??
CYDY CytoDyn Inc
05/12/2020 7:57:01 PM
What’s the mab doing a study with
CYDY CytoDyn Inc
05/12/2020 7:54:10 PM
Loved Doc L interview . I think fda (1)
CYDY CytoDyn Inc
05/12/2020 3:59:22 PM
Yes got this one though ..Like glob (1)
Go to page:
  • << First
  • < Previous
  • 27
  • 28
  • Next >

Recent Articles

  • Expected Growth in the Marine Lighting Sector to 2032
  • Cornish Metals Expands Share Capital with New Stock Options
  • Caledonia Mining Reports Improving Profitability in Gold Production
  • OSB Group Engages in Robust Share Buyback Strategy
  • Foresight Group Completes Significant Share Buyback Program
  • RIBER Reports Strong Start to 2025 with Sales Over €40M
  • CoinShares Asset Management Achieves Pioneering Regulatory Success
  • EXEL Industries Sees Revenue Decline Amid Market Challenges
  • Danske Bank's Share Transactions and Management Insights
  • Caledonia Mining Corporation's Positive Financial Outlook for 2025
  • RIBER Announces Strong Half-Year Financial Performance
  • EXEL Industries Faces Revenue Decline Amid Mixed Performance
  • Stora Enso's 2025 Half-Year Insights: Navigating Market Challenges
  • Stora Enso's Mid-Year Results: Navigating Challenges Ahead
  • Stora Enso's 2025 Half-year Results: Key Insights Revealed
  • Strong Start for Alstom in FY 2025: Orders and Sales Rise
  • KPN Achieves Impressive Growth; Forecast for 2025 Enhanced
  • Unlocking Opportunities: Prosafe SE Begins Warrant Subscription
  • Ipsen Welcomes New Leadership in Executive Committee Changes
  • Corbion Achieves Outstanding Sustainability Ratings from CDP
  • Bill Pulte: A Promising Choice for the Federal Reserve Chair
  • Hiab Reports Strong Half-Year Performance and Future Outlook
  • KPN's Impressive Q2 Performance Promises Strong 2025 Results
  • Alstom's Q1 2025/26 Report: Growth and Strong Outlook Ahead
  • GE Vernova's Promising Earnings Predictions and Analyst Ratings
  • Navigating Market Dynamics: Tech Resilience Unveiled
  • Corbion Leads in Sustainability Ratings Following CDP Evaluation
  • Latest Amendments to EfTEN United Property Fund Terms Explained
  • Roche's Innovative Blood Test Earns CE Mark for Alzheimer’s Diagnosis
  • Renault Group Showcases Resilience in Challenging Auto Market
  • BAWAG Group's Financial Highlights and Future Outlook
  • Hiab's Financial Performance Impresses in 2025 First Half
  • Roche's Anticancer Drug Itovebi Gains Approval in Europe
  • Equinor’s Robust Q2 2025 Results Highlight Growth and Strategy
  • Equinor ASA Announces Upcoming Cash Dividend Details
  • Equinor Launches Next Phase of 2025 Share Buy-Back Strategy
  • Equinor's Impressive Q2 2025 Financial Achievements Unveiled
  • Join Jay's Insightful Journey at CISCE for a Healthier Life
  • Akkodis Takes Action for Sustainable Urban Mobility with FEDORA
  • Innovative Traffic Management Boosts Sustainable Urban Mobility
  • SM Group's Commitment to Cutting Down Plastic Waste Efforts
  • SM Investments: Championing Diversity in the Workplace
  • The Future of RAN Revenue Forecast and Market Innovations
  • PayPal World Launches Global Payment Interoperability Initiative
  • Empowering Future Leaders in Hospitality Through Scholarships
  • Corporate Insiders Message: A Bearish Sentiment on Stocks
  • Countdown to CIFTIS 2025: Key Insights and Opportunities
  • Strategic Implications of Japanese PM Ishiba's Upcoming Resignation
  • Elon Musk's xAI Plans Major AI Supercluster Investment
  • Cathie Wood's Strategic Move: Investing in NVIDIA's Downturn
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site